Follow-up study of therapy in forty-eight culturally proved cases of brucellosis; streptomycin and sulfadiazine, aureomycin, and chloramphenicol (chloromycetin).
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D002006:Brucellosis / Q000628:therapy*; D002701:Chloramphenicol; D002751:Chlortetracycline; D003879:Dermatologic Agents; D005500:Follow-Up Studies; D013307:Streptomycin; D013411:Sulfadiazine / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D013411:Sulfadiazine; D002701:Chloramphenicol; D002751:Chlortetracycline; D013307:Streptomycin
ANTIBIOTICS/therapeutic use; BRUCELLOSIS/therapy; SULFADIAZINE/therapeutic use